PRoducing Outcome Measures for OTP Quality Improvement

Recruiting N/A Interventional Study
Opioid Use Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
4,500 (estimated)
Sponsor
RTI International · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a quality-improvement (QI) toolkit-either alone or with added facilitation-against usual care. Forty-…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Only BayMark OTPs are eligible for participation.
Contacts

Tami L Mark, PhD

301-816-4612

tmark@rti.org

CONTACT

Emily C Costilow, MA, PMP

910-233-7508

ecostilow@rti.org

CONTACT